Wu J - Search Results

1

A comparison of consistency of detecting BRAF gene mutations in peripheral blood and tumor tissue of nonsmall-cell lung cancer patients.

Fang M, Xu C, Wu J, Zhang Y, He C. Fang M, et al. Among authors: wu j. J Cancer Res Ther. 2014 Nov;10 Suppl:C150-4. doi: 10.4103/0973-1482.145847. J Cancer Res Ther. 2014. PMID: 25450274 Free article.

2

A comparison of consistency of detecting c-MET gene amplification in peripheral blood and tumor tissue of nonsmall cell lung cancer patients.

Chen D, Xu C, Wu J, Zhang Y, Fang M. Chen D, et al. Among authors: wu j. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C63-7. doi: 10.4103/0973-1482.163843. J Cancer Res Ther. 2015. PMID: 26323927 Free article.

3

Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.

Li L, Xu B, Zhang H, Wu J, Song Q, Yu J. Li L, et al. Among authors: wu j. J Clin Lab Anal. 2020 Jan;34(1):e23031. doi: 10.1002/jcla.23031. Epub 2019 Nov 12. J Clin Lab Anal. 2020. PMID: 31713908 Free PMC article.

4

Role of lymphocyte subsets and IL-17 in non-small cell lung cancer.

Deng C, Ren BY, Huang XP, Tan JJ, Wu JJ, Wang W, Zhu C. Deng C, et al. Among authors: wu jj. J Biol Regul Homeost Agents. 2020 Mar-Apr;34(2):319-326. doi: 10.23812/19-449-16-L. J Biol Regul Homeost Agents. 2020. PMID: 32431141 No abstract available.

5

SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer.

Dai W, Feng J, Hu X, Chen Y, Gu Q, Gong W, Feng T, Wu J. Dai W, et al. Among authors: wu j. Cancer Cell Int. 2021 Feb 15;21(1):106. doi: 10.1186/s12935-021-01781-7. Cancer Cell Int. 2021. PMID: 33632211 Free PMC article.

6

The endocytosis of nano-Pt into non-small cell lung cancer H1299 cells and intravital therapeutic effect in vivo.

Xiao Z, Huang X, Wu J, Liu T, Zhao L, Wang Q, Wang M, Shen M, Miao S, Guo D, Li H. Xiao Z, et al. Among authors: wu j. Biochem Biophys Res Commun. 2022 May 28;606:80-86. doi: 10.1016/j.bbrc.2022.03.094. Epub 2022 Mar 19. Biochem Biophys Res Commun. 2022. PMID: 35339756

7

A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.

Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, Xu B. Wu J, et al. Among authors: wu s. Oncogene. 2021 Jul;40(26):4413-4424. doi: 10.1038/s41388-021-01853-y. Epub 2021 Jun 9. Oncogene. 2021. PMID: 34108619

8

The emerging treatment landscape of targeted therapy in non-small-cell lung cancer.

Yuan M, Huang LL, Chen JH, Wu J, Xu Q. Yuan M, et al. Among authors: wu j. Signal Transduct Target Ther. 2019 Dec 17;4:61. doi: 10.1038/s41392-019-0099-9. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31871778 Free PMC article. Review.

9

Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study.

Zhen J, Wen L, Lai M, Zhou Z, Shan C, Li S, Lin T, Wu J, Wang W, Xu S, Liu D, Lu M, Zhu D, Chen L, Cai L, Zhou C. Zhen J, et al. Among authors: wu j. Radiat Oncol. 2020 Jul 31;15(1):185. doi: 10.1186/s13014-020-01627-y. Radiat Oncol. 2020. PMID: 32736566 Free PMC article.

10

[No title available]

[No authors listed] [No authors listed] PMID: 33323935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78,183 results

Search Page

Filters